SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zoracles

A sharp rally in low-cap ZORA, accompanied by higher volume, has prompted traders to discuss a possible technical breakout and speculative short squeeze tied to sizable futures positioning. The community is divided between bullish accumulation and creator/attention-market utility narratives versus warnings that the move may be a temporary pump-and-dump or reflect broader Bitcoin-driven volatility.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Speculation that SK Hynix may outsource advanced HBM base-die production to Intel Foundry has fueled interest, alongside broader expectations for additional 14A and AI-related foundry customers. Traders are largely bullish on the potential customer wins, though some caution that the SK Hynix discussions remain unconfirmed and could become a buy the rumor, sell the news event amid concerns about Intels foundry profitability.

ARK ETF Trust - ARK Innovation ETF

ARK Innovation ETF

Reported ARK Invest accumulation of SpaceX shares, including a sizable allocation in ARKK, has become the main focus, reinforcing the ETFs concentrated exposure to high-growth space and technology themes. Traders are divided between viewing the purchases as conviction in long-term innovation and criticizing the timing, valuation risk, and ARKKs prolonged underperformance.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS is drawing attention as its Phase 3 REGAL AML trial approaches the 80th death event that will trigger final efficacy analysis, with traders focused on the prospect of a major binary catalyst. Bulls point to the prolonged survival timeline and supportive comments from pharmaceutical-industry professionals, while bears debate trial design, dosing changes, censoring, and whether the delay signals control-arm strength or statistical risk.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Modernas reported positive Phase 3 cancer-vaccine result has made ARCT a sympathy trade, drawing attention to Arcturuss self-amplifying mRNA platform and related oncology potential. Bulls are also highlighting upcoming CF and OTC-deficiency milestones and short interest, while skeptics point to mixed ARCT-032 data and caution that the rally may be technically overbought.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

High-level discussions between QuantumScape and Indian officials about next-generation batteries and potential manufacturing or EV-ecosystem collaboration are fueling speculation about a new commercial opportunity in India. Traders remain divided, with bulls viewing the countrys large electric two-wheeler market as a catalyst while skeptics emphasize that concrete production, licensing, and customer milestones remain unconfirmed.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Anticipation of Oracles upcoming earnings report and its AI-cloud growth outlook is driving attention, with traders focused on its large backlog, data-center expansion and potential new contracts. Bullish participants expect a pre-earnings rally or short squeeze, while bears point to heavy debt, capex and exposure to OpenAI-related risks, including Michael Burrys reported short position.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Visas monitoring of Hims & Hers over elevated credit-card disputes tied to weight-loss memberships is driving the selloff, with traders also debating the impact of ongoing FTC scrutiny. Bulls view the reaction as overblown and continue buying dips, while bears warn the issues could hurt customer confidence and require changes to the business.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

Ongoing U.S.-Iran tensions and uncertainty over Strait of Hormuz shipping are driving attention to crude oil and UCO, with traders weighing disruption risks against reopening efforts and diplomatic progress. The community is divided, with some expecting an oil rebound from supply concerns while many cite rising production, inventories, recovering flows, and weaker demand as bearish pressures.

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Agenus Inc

Agenus is drawing attention after an institutional financing that supporters say funds the ROBBIN Phase 3 program for BOT+BAL in MSS colorectal cancer, alongside encouraging NEST/neoadjuvant data. The community is split between optimism over stronger clinical evidence, new investor oversight and reduced near-term funding risk, and concern about warrant-related dilution, the long trial timeline and managements execution history.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$DJT $TSLA $SPCX $ARKK $FLOCK.X Speak for yourself,  retard!

esipirilo

$DJT The world hates  you Trump and Musk. $TSLA $SPCX $ARKK $FLOCK.X 

Nobody wants your data centers and flock cameras